Your browser doesn't support javascript.
loading
Two Cases of Severe Amanita Muscaria Poisoning Including a Fatality.
Meisel, Ethan M; Morgan, Brent; Schwartz, Michael; Kazzi, Ziad; Cetin, Huseyin; Sahin, Aynur.
Affiliation
  • Meisel EM; Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA; Department of Emergency Medicine, Atlanta VA Healthcare System, Atlanta, GA. Electronic address: Ethan.meisel@va.gov.
  • Morgan B; Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA.
  • Schwartz M; Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA; United States Department of Health and Human Services Chemical Medical Countermeasures Branch/Biomedical Advanced Research and Development Authority/Assistant Secretary for Preparedness and Response/HHS, Washington,
  • Kazzi Z; Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA.
  • Cetin H; The Council of Forensics Medicine, Trabzon Chairmanship, Trabzon, Turkey.
  • Sahin A; Department of Emergency Medicine, Karadeniz Technical University, Trabzon, Turkey.
Wilderness Environ Med ; 33(4): 412-416, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36210279
ABSTRACT
Ingestion of Amanita muscaria mushrooms results in transient central nervous system excitation and depression mediated by its components, ibotenic acid and muscimol. The mushroom is distributed worldwide and ingestions occur with some frequency. Although these ingestions have traditionally been considered benign, serious complications can occur. We present 2 cases of serious toxicity, including a fatality. The first case was a 44-y-old man who presented to the emergency department (ED) after cardiopulmonary arrest approximately 10 h after ingesting 4 to 5 dried A muscaria mushroom caps, which he used for their mind-altering effects. Despite successful resuscitation, he remained unresponsive and hypotensive and died 9 days later. The second case was a 75-y-old man who presented to the ED after accidentally consuming one large A muscaria mushroom cap he foraged in Eastern Turkey. The patient initially presented to the ED with hallucinations followed by lethargy, and he was intubated for airway protection. The patient's condition gradually improved, and he made a full recovery. A muscaria ingestion should not be considered benign as serious outcomes do occur. An understanding of how the main neuroactive chemicals, ibotenic acid and muscimol, affect the brain can help anticipate outcomes. Several high-risk features that portend a more serious course are identified.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mushroom Poisoning Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans / Male Language: En Journal: Wilderness Environ Med Journal subject: SAUDE AMBIENTAL Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mushroom Poisoning Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans / Male Language: En Journal: Wilderness Environ Med Journal subject: SAUDE AMBIENTAL Year: 2022 Document type: Article